ABOUT
US

Team of Gplife Healthcare Pvt Ltd. Engaged in research and development in the last 17 Years in Phytochemistry and AI Statistical model to solve chronic diseases and its symptoms by Phytoconstituents/Phytochemicals Synergy effect. Additionally, we replaced all unscientific excipients mechanisms with Active ingredients (Phytocompound) with this Algorithm to increase therapeutic effects & minimize side-effects to make healthcare noble again and create revolution in the healthcare industry. We, Team of Gplife developed an algorithm and Statistical model of 300+ phytochemical and its synergy effect to regenerate cells to solve chronic diseases like Diabetes (Type-1, Type-2), Covid-19, Arthritis (RA, OA), NAFLD, AFLD, Chronic Kidney diseases, cardiovascular disease (Hyperlipidaemia), Gut disease, respiratory problem, Vitamin deficiency, Neurological disease and many more. Gplife engaged in IPR (Patent), CRO (clinical research) and OEM (Research & Development) for last 17 years. We have succeeded in Human Clinical trials, case study and animal study as per regulatory guidelines. Present, we have 50+ products with tremendous outcomes in different health areas.

Director Message

Dr. Chetan Savaliya

Team of Gplife Healthcare Pvt Ltd. Engaged in research and development since 2006 in Phytochemistry and AI Statistical model to solve chronic diseases and its symptoms by Phytoconstituents/Phytochemicals Synergistic effect. Additionally, we replaced all unscientific excipients mechanisms with Active ingredients (Phytocompound) with this Algorithm to increase therapeutic effects & minimize side-effects to make healthcare noble again and create revolution in the healthcare industry. We, Team of Gplife developed an algorithm and Statistical model of 300+ phytochemical and its synergy effect to regenerate cells to solve chronic diseases like Diabetes, Covid-19, Arthritis, Liver disease- NAFLD, Chronic Kidney diseases, Cardiovascular disease, Gut disease, Respiratory problem, Lung’s disease, Vitamin’s deficiency, Neurological disease and many more. We, Gplife developed Patented excipientless OEM for immediate therapeutic action and prolonged safe dosage. All products passed stability, quality and evaluation as per NABL lab. Gplife engaged in Safety, clinical studies and research development since 2006. We have succeeded in Human Clinical trials, case study and animal study as per ethical guidelines. At present, we have 50+ products with tremendous outcomes in different health areas. In Gplife, we are able to satisfy all these requirements by way of a new scientific mechanism to target the causality to solve disease using a novel pharmacological approach. In many of our clinical trials in various areas, the results are already excellent due to the fact that our primary focus is always on causality and treating diseases and not only to simply masking the symptoms of diseases. We believe this is a revolution in the field of healthcare and that it’s just starting.